TaiMed Biologics Statistics
Total Valuation
TPEX:4147 has a market cap or net worth of TWD 24.60 billion. The enterprise value is 23.47 billion.
Market Cap | 24.60B |
Enterprise Value | 23.47B |
Important Dates
The last earnings date was Tuesday, March 25, 2025.
Earnings Date | Mar 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TPEX:4147 has 273.08 million shares outstanding. The number of shares has increased by 6.08% in one year.
Current Share Class | n/a |
Shares Outstanding | 273.08M |
Shares Change (YoY) | +6.08% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 1.45% |
Owned by Institutions (%) | 5.39% |
Float | 185.59M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 39.60 |
PB Ratio | 6.12 |
P/TBV Ratio | 7.06 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -116.31 |
EV / Sales | 38.47 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -60.56 |
Financial Position
The company has a current ratio of 25.18, with a Debt / Equity ratio of 0.13.
Current Ratio | 25.18 |
Quick Ratio | 13.26 |
Debt / Equity | 0.13 |
Debt / EBITDA | n/a |
Debt / FCF | -1.35 |
Interest Coverage | -20.01 |
Financial Efficiency
Return on equity (ROE) is -6.13% and return on invested capital (ROIC) is -4.01%.
Return on Equity (ROE) | -6.13% |
Return on Assets (ROA) | -3.55% |
Return on Invested Capital (ROIC) | -4.01% |
Return on Capital Employed (ROCE) | -5.19% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.14 |
Inventory Turnover | 0.28 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.89% in the last 52 weeks. The beta is 0.21, so TPEX:4147's price volatility has been lower than the market average.
Beta (5Y) | 0.21 |
52-Week Price Change | -1.89% |
50-Day Moving Average | 92.78 |
200-Day Moving Average | 85.57 |
Relative Strength Index (RSI) | 39.74 |
Average Volume (20 Days) | 1,961,724 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4147 had revenue of TWD 610.16 million and -201.83 million in losses. Loss per share was -0.75.
Revenue | 610.16M |
Gross Profit | 211.23M |
Operating Income | -252.27M |
Pretax Income | -201.83M |
Net Income | -201.83M |
EBITDA | -104.49M |
EBIT | -252.27M |
Loss Per Share | -0.75 |
Balance Sheet
The company has 1.65 billion in cash and 522.63 million in debt, giving a net cash position of 1.13 billion or 4.14 per share.
Cash & Cash Equivalents | 1.65B |
Total Debt | 522.63M |
Net Cash | 1.13B |
Net Cash Per Share | 4.14 |
Equity (Book Value) | 4.02B |
Book Value Per Share | 14.73 |
Working Capital | 3.26B |
Cash Flow
In the last 12 months, operating cash flow was -379.55 million and capital expenditures -8.06 million, giving a free cash flow of -387.61 million.
Operating Cash Flow | -379.55M |
Capital Expenditures | -8.06M |
Free Cash Flow | -387.61M |
FCF Per Share | -1.42 |
Margins
Gross margin is 34.62%, with operating and profit margins of -41.34% and -33.08%.
Gross Margin | 34.62% |
Operating Margin | -41.34% |
Pretax Margin | -33.08% |
Profit Margin | -33.08% |
EBITDA Margin | -17.13% |
EBIT Margin | -41.34% |
FCF Margin | n/a |
Dividends & Yields
TPEX:4147 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.08% |
Shareholder Yield | -6.08% |
Earnings Yield | -0.82% |
FCF Yield | -1.58% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TPEX:4147 has an Altman Z-Score of 14.49.
Altman Z-Score | 14.49 |
Piotroski F-Score | n/a |